ZeptoMetrix Adenovirus Rapid Test Control Pack, Quantity: 1.5mL, Certifications/Compliance: ISO 13485, Format: Solution, For Use With: In vitro rapid tests for the determination of the presence or absence of Adenovirus, Media Type: Vial, St
ZeptoMetrix Adenovirus Rapid Test Control Pack, Quantity: 1.5mL, Certifications/Compliance: ISO 13485, Format: Solution, For Use With: In vitro rapid tests for the determination of the presence or absence of Adenovirus, Media Type: Vial, St
ZeptoMetrix Rotavirus Rapid Test Control Pack, Quantity: 1.5mL, Certifications/Compliance: ISO 13485, Format: Solution, For Use With: In vitro rapid tests for the determination of the presence or absence of Rotavirus, Media Type: Vial, Stor
ZeptoMetrix Influenza Rapid Test Control Pack, Quantity: 1.5mL, Certifications/Compliance: ISO 13485, Format: Solution, For Use With: In vitro rapid tests for the determination of the presence or absence of Influenza A and B, Media Type: Vi
ZeptoMetrix Respiratory Syncytial Virus (RSV) Rapid Test Control Pack, Quantity: 1.5mL, Certifications/Compliance: ISO 13485, Format: Solution, For Use With: In vitro rapid tests for the determination of the presence or absence of RSV, Medi
ZeptoMetrix Respiratory Verification Panel, Quantity: 1.5mL, Certifications/Compliance: ISO 13485, Format: Solution, For Use With: In vitro rapid tests for the determination of the presence or absence of Influenza A/B, RSV, Adenovirus and R
ZeptoMetrix SeroDetect HIV Antibody Panel, Biosafety Level: 2, Format: Solution, For Use With: In vitro assay procedures for the determination of Antibodies to HIV Types 1 and 2., Media Type: Vial, Quantity: 5 x 1.5mL, Shelf Life: 60 Days,
ZeptoMetrix NATtrol CT/NG Negative Control Pack, For Use With: Quality control of clinical assays and training of laboratory personnel, Quantity: 6 x 1.25mL Vials, Storage Requirements: 2 to 8 deg.C, Recommended Applications: Healthcare, CT
ZeptoMetrix NATtrol Norovirus GII Virus, Certifications/Compliance: ISO, 13485, Format: Solution, For Use With: Determination of presence of Norovirus GII RNA, validation of clinical assays, development of diagnostic tests and training of l